The Safety and Efficacy of Lansoprazole plus Metoclopramide among Neonates with Gastroesophageal Reflux Disease Resistant to Conservative Therapy and Monotherapy: A Clinical Trial
Table 4
GERD-related clinical manifestation scoring, before and one month after intervention.
GERD clinical manifestations
Mean preintervention
value
Mean one month after intervention
value
Ranitidine plus metoclopramide (group A)
Lansoprazole plus metoclopramide (group B)
Ranitidine plus metoclopramide (group A)
Lansoprazole plus metoclopramide (group B)
Weight
0.835
0.324
Vomiting intensity
0.835
0.006
Vomiting volume
0.912
0.695
Refusal feeding
0.781
0.044
Refusal feeding contrary being hungry
0.714
0.032
Crying before and after feeding
0.219
0.09
Crying duration
0.360
0.058
Hiccup
0.142
0.353
Arching
0.084
0.018
Vomiting associated with irritability and lethargy
